Nov 29, 2023 / 01:20PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
All right. Well, looking forward to this discussion going from human vaccines to animal vaccines and beyond. Todd, really looking forward to discussion. Thank you for joining us. I feel like there's been quite a few developments over the last couple of years, but I also think much of the pipeline story, which was sort of this -- a big thesis that was going to play out in due time is now upon us. And so it's a very important year for you guys coming up, truly very important after all this time. Let me have you kick things off and we'll start to go again.
Todd S. Young - Elanco Animal Health Incorporated - Executive VP & CFO
No, certainly. And thanks, Mike. Thanks, Umer for having us at the conference and everyone turning out. This is a pivotal year for Elanco as our innovation pipeline is starting to produce. This year, we've seen the ramp of Experior, which is our ammonia reduction product and feedlots finally ramping after a slower start
Elanco Animal Health Inc at Evercore ISI HealthCONx Conference Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers